EA202192046A1 - SYSTEMS AND METHODS FOR EXTRACORPORAL HYPERTHERMAL PERFUSION (EHP) THERAPY - Google Patents
SYSTEMS AND METHODS FOR EXTRACORPORAL HYPERTHERMAL PERFUSION (EHP) THERAPYInfo
- Publication number
- EA202192046A1 EA202192046A1 EA202192046A EA202192046A EA202192046A1 EA 202192046 A1 EA202192046 A1 EA 202192046A1 EA 202192046 A EA202192046 A EA 202192046A EA 202192046 A EA202192046 A EA 202192046A EA 202192046 A1 EA202192046 A1 EA 202192046A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- ehp
- therapy
- extracorporal
- systems
- methods
- Prior art date
Links
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Настоящее изобретение относится к системе для нагревания крови, в частности, для выполнения экстракорпоральной гипертермической перфузионной (EHP) терапии. Настоящее изобретение дополнительно относится к экстракорпоральной крови, нагретой выше нормальной температуры тела, для использования при лечении заболевания, выбранного из группы, состоящей из рака, аутоиммунного заболевания, инфекционного заболевания, воспалительного заболевания и сепсиса. Кроме того, настоящее изобретение относится к комбинации экстракорпоральной крови, нагретой выше нормальной температуры тела, и химиотерапевтического средства для использования при лечении рака.The present invention relates to a blood heating system, in particular for performing extracorporeal hyperthermic perfusion (EHP) therapy. The present invention further relates to extracorporeal blood heated above normal body temperature for use in the treatment of a disease selected from the group consisting of cancer, autoimmune disease, infectious disease, inflammatory disease, and sepsis. In addition, the present invention relates to a combination of extracorporeal blood heated above normal body temperature and a chemotherapeutic agent for use in the treatment of cancer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19153556 | 2019-01-24 | ||
PCT/EP2019/070811 WO2020151841A1 (en) | 2019-01-24 | 2019-08-01 | System and methods for extracorporeal hyperthermia perfusion (ehp) therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202192046A1 true EA202192046A1 (en) | 2021-11-11 |
Family
ID=65234421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202192046A EA202192046A1 (en) | 2019-01-24 | 2019-08-01 | SYSTEMS AND METHODS FOR EXTRACORPORAL HYPERTHERMAL PERFUSION (EHP) THERAPY |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3914312A1 (en) |
DE (1) | DE202019005458U1 (en) |
EA (1) | EA202192046A1 (en) |
WO (1) | WO2020151841A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022040376A2 (en) * | 2020-08-21 | 2022-02-24 | Verthermia Acquisition, Inc. | Improved method and system for controlled hyperthermia |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2371781C (en) * | 1999-05-25 | 2008-07-22 | Viacirq, Inc. | Hyperthermia method and apparatus |
WO2015123645A2 (en) * | 2014-02-17 | 2015-08-20 | Spearman Patrick Richard | Systems and methods for treating blood |
EP3531991A1 (en) * | 2016-10-31 | 2019-09-04 | Elmedix Bvba | Whole-body hyperthermia system |
-
2019
- 2019-08-01 EP EP19745181.8A patent/EP3914312A1/en active Pending
- 2019-08-01 DE DE202019005458.8U patent/DE202019005458U1/en active Active
- 2019-08-01 WO PCT/EP2019/070811 patent/WO2020151841A1/en unknown
- 2019-08-01 EA EA202192046A patent/EA202192046A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3914312A1 (en) | 2021-12-01 |
WO2020151841A1 (en) | 2020-07-30 |
DE202019005458U1 (en) | 2020-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hong et al. | Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial | |
PH12019500504A1 (en) | Individual difference information management system in dialysis treatment | |
MX2023006353A (en) | Internal ultraviolet therapy. | |
Kasimov et al. | Efficacy of modified hemosorbents user for treatment of patients with multi-organ insufficiency | |
JP2013507379A5 (en) | ||
WO2015049688A3 (en) | Patient-specific immunotherapy for treating heterogeneous tumors | |
EA202192046A1 (en) | SYSTEMS AND METHODS FOR EXTRACORPORAL HYPERTHERMAL PERFUSION (EHP) THERAPY | |
BR112022010905A2 (en) | ANTI-CD38 ANTIBODY FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION | |
MX2019006141A (en) | Methods of treating inflammatory disorders with multivalent fc compounds. | |
Howell | Second primary cancers and cardiovascular disease after radiation therapy. NCRP report no. 170 | |
Broman et al. | Intra-arterial perfusion-based therapies for regionally metastatic cutaneous and uveal melanoma | |
Lionnet et al. | Iron restriction is an important treatment of hemoglobin SC disease | |
Panchenko et al. | Cryotherapy as part of the post-stress disorder rehabilitation complex | |
Kwon et al. | Acupuncture therapy for fever induced by viral upper respiratory tract infection (URTI) in military medical service: a case series | |
Yeh et al. | Is the renoprotective effect of erythropoietin in chronic kidney disease a myth? | |
Budlovsky | Finding the humanity: Learning to listen in emergency medicine | |
Chudakova et al. | Effectiveness of antiviral therapy for acute respiratory viral infections in frequently ill children | |
Pakzad et al. | Blood transfusions in severe burn patients: Epidemiology and predictive factors: Methodological issues | |
Minervini et al. | Re: Renal Cancer Surgery for Patients Without Preexisting Chronic Kidney Disease: Is There a Survival Benefit for Partial Nephrectomy? | |
Ducharme-Crevier et al. | Childhood stroke and congenital heart disease | |
Xiaonong et al. | New insights into the diagnosis and treatment of hyperkalemia in patients with chronic kidney disease | |
Toh et al. | Concomitant Limb Cryocompression And Scalp Cooling To Reduce Paclitaxel-Induced Neuropathy And Alopecia | |
UA104218U (en) | Apparatus for extracorporeal blood hyperthermia | |
Yacob | Clinical Microbiology and Infectious Diseases | |
de Bondeville | 500 mL/min, blood flow rate of 350 mL/min, low flux dialyzers F6 and monitors Fresenius 4008 S), CVC filled with citrate. Platelet count revised (Fig. 1). In January 2014 (284 days after heparins dis |